Skip to main content

Table 1 Baseline characteristics of patients with lung adenocarcinoma in the training cohort

From: Identification and validation of an immune cell infiltrating score predicting survival in patients with lung adenocarcinoma

Variable

Baseline characteristics (n = 751)

Affymetrix® platform

 HG-U133 Plus 2.0 (GPL570)

313 (41.7)

 HG-U133A (GPL96)

438 (58.3)

Age

64.6 ± 10.0

Sex

 Male

394 (52.5)

 Female

357 (47.5)

Tumor stage

 Stage I

515 (68.6)

 Stage II–III

232 (30.9)

 Stage IV

4 (0.5)

Smoking status

 Current smoker

67 (8.9)

 Ex-smoker

322 (42.9)

 Non-smoker

71 (9.5)

 Unknown

291 (38.7)

Adjuvant chemotherapy

 Yes

102 (13.6)

 No

377 (50.2)

 Unknown

272 (36.2)

  1. Continuous data (age) was presented as mean ± standard deviation and categorical data as number (proportion of that the subgroup accounted for the whole group)